Celularity remains out of compliance with Nasdaq periodic reporting rule due to delayed SEC filings
C
CELU• Nasdaq reporting deficiency remains open
- Nasdaq confirmed on Sept. 11, 2026 that Celularity regained compliance with the minimum bid price and market value of listed securities rules.
A separate Nasdaq deficiency remains open over delayed SEC periodic filings under Listing Rule 5250(c)(1).Celularity is working to complete the overdue filings to restore compliance with Nasdaq’s reporting requirement.SRRK
•
Celularity remains out of compliance with Nasdaq periodic reporting rule due to delayed SEC filings - CELU News | Rallies